Barrett Hodgson Pakistan products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi-based pharmaceutical manufacturer with a broad branded portfolio and partnerships with international healthcare companies.
Barrett Hodgson Pakistan products in Pakistan
Barrett Hodgson Pakistan (Pvt.) Ltd has 187 medicine presentations registered in Pakistan under 66 brands, covering 63 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and CNS & mental health. Its brands with the most registered strengths and packs are Barlev (Levetiracetam), Telbar Plus (Telmisartan + Amlodipine), Inoquin (Ciprofloxacin) and Entebar (Entecavir). 187 products have an official DRAP price on MedInfoBase. See all 66 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Barrett Hodgson Pakistan (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- F/423, S.I.T.E., Karachi-75700, Pakistan · 75700
- Website
- barretthodgson.com ↗
- Phone
- +92 21 32570651-57
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Barrett Hodgson Pakistan (Pvt.) Ltd is priced against the market
166 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| No matching products. | ||||||||
All 66 Barrett Hodgson Pakistan brands in Pakistan
- Adgam Eye Latanoprost · 0.05 mg/mL drops
- Adgam-T Latanoprost + Timolol · 0.05 mg/mL + 5 mg/mL drops
- Ampress Amlodipine · 10 mg tablet, 5 mg tablet
- Bar-D Cholecalciferol · 5 mg/mL (200,000 IU/mL) injection
- Barforte Prednisolone · 10 mg/mL suspension
- Barigyl Metronidazole, Metronidazole (Benzoate) · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
- Barilol Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Barilol-H Bisoprolol + Hydrochlorothiazide · 10 mg + 6.25 mg tablet, 2.5 mg + 6.25 mg tablet, 5 mg + 6.25 mg tablet
- Barimox Moxifloxacin · 400 mg tablet
- Baripenem Meropenem · 1 g injection, 500 mg injection
- Barizold Linezolid · 100 mg/5 mL suspension, 200 mg/100 mL infusion, 400 mg tablet
- Barlev Levetiracetam · 100 mg/mL solution, 1000 mg tablet, 250 mg tablet
- Barotrop 18mcg DPI Tiotropium · 18 mcg capsule
- Barresten Clotrimazole · 1% cream, 100 mg/g (10%) cream, 2% cream
- Barresten HC Clotrimazole + Hydrocortisone · 1% + 1% w/w cream, 10 mg/g + 10 mg/g cream
- Britanyl Terbutaline Terbutaline · 0.5 mg/mL injection
- Budecort-F Budesonide + Formoterol · 100 mcg + 6 mcg inhalation, 200 mcg + 6 mcg inhalation
- Cefamezin Cefazolin · 1 g injection, 250 mg injection, 500 mg injection
- Cefcom Ceftazidime · 1000 mg injection, 250 mg injection, 500 mg injection
- Cefspan Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
- Cefspan DS Cefixime · 200 mg/5 mL suspension
- Cipotic Ciprofloxacin · 3 mg/mL drops
- Clotnil Clopidogrel · 75 mg tablet
- Clotnil Plus Clopidogrel + Aspirin · 75 mg + 150 mg tablet, 75 mg + 75 mg tablet
- Co-TelBar Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet, 80 mg + 25 mg tablet
- Curox Cefuroxime · 1500 mg injection, 250 mg injection, 750 mg injection
- Dynaquin Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Entebar Entecavir · 0.5 mg tablet, 1 mg tablet
- Exonex Ofloxacin · 3 mg/mL solution
- Febrol Paracetamol · 120 mg/5 mL suspension, 250 mg/5 mL suspension, 500 mg tablet
- Febrol Infant Paracetamol · 80 mg/0.8 mL drops
- Gifah Acetylsalicylic acid (Aspirin) · 75 mg tablet
- Gixer Cetirizine · 5 mg/5 mL solution
- Hepgard Sofosbuvir · 400 mg tablet
- Hepgard-V Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
- Heprix - B Lamivudine · 100 mg tablet
- Inocef Ceftriaxone · 1 g injection, 1000 mg injection, 2000 mg injection
- Inoquin Ciprofloxacin · 100 mg/50 mL infusion, 125 mg/5 mL suspension, 200 mg/100 mL infusion
- Iprabar nebulizing Ipratropium Ipratropium bromide · 250 mcg/mL solution
- Levure Fluconazole · 10 mg/mL suspension, 100 mg/50 mL infusion, 150 mg capsule
- LIDOCAINE Lidocaine · 1 % solution
- Losec Omeprazole · 20 mg capsule
- MalEra Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 40 mg injection, 40 mg + 240 mg tablet
- Mazox Azithromycin · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 250 mg capsule
- Megaklar Clarithromycin · 125 mg/5 mL drops, 125 mg/5 mL suspension, 250 mg tablet
- MetBar ER Metformin · 500 mg tablet
- Oflopred Prednisolone acetate + Ofloxacin · 10 mg/mL + 3 mg/mL suspension
- Persch Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Polyfer FA Iron polymaltose complex + Folic acid · 100 mg elemental iron + 350 mcg folic acid tablet
- Polyfer Iron (III) Hydroxide polymaltose complex Iron polymaltose complex · 100 mg tablet, 50 mg/5 mL syrup
- Recol Simvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Reform Sumatriptan · 50 mg tablet
- Rivaclot Rivaroxaban · 10 mg tablet, 15 mg tablet, 2.5 mg tablet
- Sartan Losartan · 25 mg tablet, 50 mg tablet
- Sartan-H Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
- Scanil Permethrin · 5% cream
- Silpor Silver Silver sulfadiazine · 1 % cream
- Soludex-4 Dexamethasone · 4 mg/1 mL injection
- Synibac Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
- Telbar Plus Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 40 mg tablet, 40 mg + 5 mg tablet
- Victrin Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Wintax Cefotaxime · 1 g injection, 2 g injection, 250 mg injection
- Xyloaid Lidocaine · 2% injection, 4% solution, 5 % ointment
- Xyloaid with Adrenaline Lidocaine + Adrenaline · 2% + 0.0005% injection
- Zoran Ranitidine · 150 mg tablet, 50 mg/2 mL injection, 75 mg/5 mL suspension
- Zoran DS Ranitidine · 300 mg tablet
Barrett Hodgson Pakistan: common questions
How many products does Barrett Hodgson Pakistan have in Pakistan?
Barrett Hodgson Pakistan (Pvt.) Ltd has 187 registered medicine presentations in Pakistan, sold under 66 brands and covering 63 generic medicines.
What are the main brands of Barrett Hodgson Pakistan?
By number of registered strengths and packs, its largest brands are Barlev (Levetiracetam), Telbar Plus (Telmisartan + Amlodipine), Inoquin (Ciprofloxacin), Entebar (Entecavir) and Inocef (Ceftriaxone). This is not a sales ranking.
Which therapy areas does Barrett Hodgson Pakistan cover?
The most products are in Anti-infectives (99), Cardiovascular (28), CNS & mental health (15), Respiratory & allergy (11) and Hematology & thrombosis (8).
Where can I see Barrett Hodgson Pakistan medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.